From a proteomic perspective, early evidence from Haitel and colleagues demonstrated that the MDM2 protein is overexpressed in RCC tissues and serves as a marker of poor prognosis and reduced survival [22]. This evidence concerns the gene MDM2 and renal cell carcinoma.